NSC
64
2
KO
44
2
DD
61
4
STX
52
-4
TEL
74
3
PDCO
30
-6
CVX
38
6
DGX
48
-3
PSA
58
5
CMS
58
-2
WFC
80
-2
AMAT
43
-5
DOW
30
2
ROK
67
5
DVA
72
-3
EW
32
3
MPC
47
3
SYY
47
-2
VLO
42
2
EFX
41
-2
NSC
64
2
KO
44
2
DD
61
4
STX
52
-4
TEL
74
3
PDCO
30
-6
CVX
38
6
DGX
48
-3
PSA
58
5
CMS
58
-2
WFC
80
-2
AMAT
43
-5
DOW
30
2
ROK
67
5
DVA
72
-3
EW
32
3
MPC
47
3
SYY
47
-2
VLO
42
2
EFX
41
-2
Financhill
Back

Genmab AS Vs. ePlus Industry Stock Comparison

Sell
32

GMAB
Genmab AS

Last Price:
21.21
Seasonality Move:
3.28%
Sell
27

PLUS
ePlus

Last Price:
80.50
Seasonality Move:
20.86%
Sell
32
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GMAB] share price is $21.67. The Score for GMAB is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
ePlus (PLUS) is a Sell

Is ePlus a Buy, Sell or Hold?

  • The current ePlus [PLUS] share price is $80.03. The Score for PLUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $21.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing selling pressure, which indicates risk of future bearish movement.

PLUS Stock Price Chart

What is ePlus's stock price today?

  • The ePlus share price today is $80.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLUS is experiencing selling pressure, which indicates risk of future bearish movement.

GMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 32.32 Sell
Chaikin Money Flow: -1905875 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.44 - 23.32) Sell
Bollinger Bands (100): (23.53 - 27.49) Sell

PLUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.37 Sell
Relative Strength Index (14 RSI): 28.12 Sell
Chaikin Money Flow: -371573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.15 - 100.85) Sell
Bollinger Bands (100): (81.19 - 98.29) Sell

GMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.67 Sell
20-day SMA: 22.76 Sell
50-day SMA: 24.08 Sell
200-day SMA: 27.13 Sell
8-day EMA: 22.56 Sell
20-day EMA: 22.87 Sell
50-day EMA: 23.9 Sell
200-day EMA: 27.12 Sell

PLUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 93.25 Sell
20-day SMA: 94.97 Sell
50-day SMA: 95.27 Sell
200-day SMA: 83.59 Sell
8-day EMA: 92.26 Sell
20-day EMA: 94.28 Sell
50-day EMA: 94.05 Sell
200-day EMA: 84.44 Sell

Genmab AS Earnings Growth & GMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.29 per share.

ePlus Earnings Growth & PLUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ePlus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):